UK scientists slow Huntington's disease for first time

UK researchers announced a breakthrough gene therapy that slowed Huntington's disease for the first time. Early-stage trials at University College London showed some patients’ condition progressed 75% slower over three years. The therapy, AMT-130, is delivered via direct brain injection.